These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 8384316

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 3. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study.
    Vaziri SM, Evans JC, Larson MG, Wilson PW.
    Arch Intern Med; 1993 Oct 11; 153(19):2200-6. PubMed ID: 8215723
    [Abstract] [Full Text] [Related]

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Oct 11; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 5. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul 11; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 11; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM, Johns JA, McCloud PI, Davis SR.
    N Engl J Med; 1997 Aug 28; 337(9):595-601. PubMed ID: 9271481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D.
    N Engl J Med; 2000 Aug 24; 343(8):522-9. PubMed ID: 10954759
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S, Hitchcock CL, Sirrs S, Pudek M, Prior JC.
    Pharmacotherapy; 2010 May 24; 30(5):442-52. PubMed ID: 20411996
    [Abstract] [Full Text] [Related]

  • 12. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug 24; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; 2006 Aug 24; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

  • 15. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S, Velazquez E, Osona A, Hamer T, Glueck CJ.
    J Lab Clin Med; 1994 Jun 24; 123(6):837-41. PubMed ID: 8201261
    [Abstract] [Full Text] [Related]

  • 16. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 17. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin.
    Miller VT, Muesing RA, LaRosa JC, Stoy DB, Fowler SE, Stillman RJ.
    Obstet Gynecol; 1994 Feb 20; 83(2):173-9. PubMed ID: 8290177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators.
    N Engl J Med; 2003 Aug 07; 349(6):523-34. PubMed ID: 12904517
    [Abstract] [Full Text] [Related]

  • 20. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH.
    N Engl J Med; 1991 Sep 12; 325(11):756-62. PubMed ID: 1870648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.